Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Will Stone

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Microbe|May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, MaliAlmahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
Plos Medicine|August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant dataLeen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
The Lancet. Microbe|May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialWill Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Nature Communications|April 27, 2021
Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infectionsAissata Barry, John Bradley, Will Stone, et al.
Research Square|February 23, 2026
The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adultsTeun Bousema, Sara Lynn Blanken, Patience Nayabare, et al.
Elife|June 1, 2018
Predicting the likelihood and intensity of mosquito infection from sex specific <i>Plasmodium falciparum</i> gametocyte densityJohn Bradley, Will Stone, Dari F Da, et al.
Scientific Reports|January 12, 2018
Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasitesLisette Meerstein-Kessel, Robin van der Lee, Will Stone, et al.
Nature Communications|October 28, 2017
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensityBronner P Gonçalves, Melissa C Kapulu, Patrick Sawa, et al.
The Lancet. Microbe|July 28, 2024
Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trialKatharine A Collins, Alphonse Ouedraogo, Wamdaogo Moussa Guelbeogo, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Microbe|May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, MaliAlmahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
Plos Medicine|August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant dataLeen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
The Lancet. Microbe|May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialWill Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Nature Communications|April 27, 2021
Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infectionsAissata Barry, John Bradley, Will Stone, et al.
Research Square|February 23, 2026
The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adultsTeun Bousema, Sara Lynn Blanken, Patience Nayabare, et al.
Elife|June 1, 2018
Predicting the likelihood and intensity of mosquito infection from sex specific <i>Plasmodium falciparum</i> gametocyte densityJohn Bradley, Will Stone, Dari F Da, et al.
Scientific Reports|January 12, 2018
Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasitesLisette Meerstein-Kessel, Robin van der Lee, Will Stone, et al.
Nature Communications|October 28, 2017
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensityBronner P Gonçalves, Melissa C Kapulu, Patrick Sawa, et al.
The Lancet. Microbe|July 28, 2024
Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trialKatharine A Collins, Alphonse Ouedraogo, Wamdaogo Moussa Guelbeogo, et al.
Pageof 3